127 related articles for article (PubMed ID: 17619133)
41. Nucleotide sequence analysis of Marek's disease virus (MDV) serotype 2 homolog of MDV serotype 1 pp38, an antigen associated with transformed cells.
Ono M; Kawaguchi Y; Maeda K; Kamiya N; Tohya Y; Kai C; Niikura M; Mikami T
Virology; 1994 May; 201(1):142-6. PubMed ID: 8178479
[TBL] [Abstract][Full Text] [Related]
42. Expression and purification of recombinant Marek's disease virus serotype 1 specific phosphorylated protein pp38 in E. coli.
Endoh D; Niikura M; Hirai K; Inagaki N; Hayashi M; Nakajima K; Sato F
J Vet Med Sci; 1994 Oct; 56(5):823-6. PubMed ID: 7865579
[TBL] [Abstract][Full Text] [Related]
43. Comparative transcriptional activity of five promoters in BAC-cloned MDV for the expression of the hemagglutinin gene of H9N2 avian influenza virus.
Ma C; Zhang Z; Zhao P; Duan L; Zhang Y; Zhang F; Chen W; Cui Z
J Virol Methods; 2014 Sep; 206():119-27. PubMed ID: 24893109
[TBL] [Abstract][Full Text] [Related]
44. Interactions between Marek's disease virus Rispens/CVI988 vaccine strain and adenovirus field strain in chicken embryo fibroblast (CEF) cultures.
Niczyporuk JS; Woźniakowski G; Samorek-Salamonowicz E; Czekaj H
Pol J Vet Sci; 2014; 17(1):3-8. PubMed ID: 24724464
[TBL] [Abstract][Full Text] [Related]
45. [Comparison of the relative luciferase activity in secondary CEF by different heterogenous strong promoters, MDV gB promoter and the composed promoters].
Qiu YF; Ge FF; Xu XQ; Chen PY
Wei Sheng Wu Xue Bao; 2006 Apr; 46(2):314-7. PubMed ID: 16736599
[TBL] [Abstract][Full Text] [Related]
46. [Construction of Marek's disease virus serotype 814 strain as an infectious bacterial artificial chromosome].
Cui H; Wang Y; Shi X; Tong G; Lan D; He L; Qiu H; Liu C; Wang M
Sheng Wu Gong Cheng Xue Bao; 2008 Apr; 24(4):569-75. PubMed ID: 18616164
[TBL] [Abstract][Full Text] [Related]
47. Syngeneic Marek's disease virus (MDV)-specific cell-mediated immune responses against immediate early, late, and unique MDV proteins.
Omar AR; Schat KA
Virology; 1996 Aug; 222(1):87-99. PubMed ID: 8806490
[TBL] [Abstract][Full Text] [Related]
48. Rescue of synthetic measles virus minireplicons: measles genomic termini direct efficient expression and propagation of a reporter gene.
Sidhu MS; Chan J; Kaelin K; Spielhofer P; Radecke F; Schneider H; Masurekar M; Dowling PC; Billeter MA; Udem SA
Virology; 1995 Apr; 208(2):800-7. PubMed ID: 7747454
[TBL] [Abstract][Full Text] [Related]
49. Quail cell lines supporting replication of Marek's disease virus serotype 1 and 2 and herpesvirus of turkeys.
Li X; Schat KA
Avian Dis; 2004 Dec; 48(4):803-12. PubMed ID: 15666861
[TBL] [Abstract][Full Text] [Related]
50. Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2).
Burysek L; Yeow WS; Pitha PM
J Hum Virol; 1999; 2(1):19-32. PubMed ID: 10200596
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of measles virus minireplicon-encoded reporter gene expression by V protein.
Witko SE; Kotash C; Sidhu MS; Udem SA; Parks CL
Virology; 2006 Apr; 348(1):107-19. PubMed ID: 16445957
[TBL] [Abstract][Full Text] [Related]
52. Transcriptional activity comparison of different sites in recombinant Marek's disease virus for the expression of the H9N2 avian influenza virus hemagglutinin gene.
Zhang F; Chen W; Ma C; Zhang Z; Zhao P; Du Y; Zhang Y; Duan L; Fang J; Li S; Su H; Cui H; Cui Z
J Virol Methods; 2014 Oct; 207():138-45. PubMed ID: 25034124
[TBL] [Abstract][Full Text] [Related]
53. Development of a sustainable chick cell line infected with Marek's disease virus.
Abujoub A; Coussens PM
Virology; 1995 Dec; 214(2):541-9. PubMed ID: 8553556
[TBL] [Abstract][Full Text] [Related]
54. [Immunological cross-reaction of serotype I Marek's disease virus 38kD phosphorylated protein with serotype II and III viruses].
Qin A; Cui Z; Duan Y
Wei Sheng Wu Xue Bao; 1994 Oct; 34(5):393-7. PubMed ID: 7871782
[TBL] [Abstract][Full Text] [Related]
55. Cis-acting elements in the lytic origin of DNA replication of Marek's disease virus type 1.
Katsumata A; Iwata A; Ueda S
J Gen Virol; 1998 Dec; 79 ( Pt 12)():3015-8. PubMed ID: 9880016
[TBL] [Abstract][Full Text] [Related]
56. Interactions between Marek's disease virus encoded or induced factors and the Rous sarcoma virus long terminal repeat promoter.
Banders UT; Coussens PM
Virology; 1994 Feb; 199(1):1-10. PubMed ID: 8116231
[TBL] [Abstract][Full Text] [Related]
57. Association between rate of viral genome replication and virulence of Marek's disease herpesvirus strains.
Yunis R; Jarosinski KW; Schat KA
Virology; 2004 Oct; 328(1):142-50. PubMed ID: 15380365
[TBL] [Abstract][Full Text] [Related]
58. Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.
de Lucas S; Bartolome J; Carreno V
J Infect Dis; 2005 Jan; 191(1):93-9. PubMed ID: 15593009
[TBL] [Abstract][Full Text] [Related]
59. Transcriptional and Bioinformatic Analysis Provide a Relationship between Host Response Changes to Marek's Disease Viruses Infection and an Integrated Long Terminal Repeat.
Cui N; Li X; Chen C; Hao H; Su S; Cui Z
Front Cell Infect Microbiol; 2016; 6():46. PubMed ID: 27200301
[TBL] [Abstract][Full Text] [Related]
60. Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression.
Lyles DS; McKenzie MO; Ahmed M; Woolwine SC
Virology; 1996 Nov; 225(1):172-80. PubMed ID: 8918544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
